Arkolith/Insider Trading/ANIP/Form 4

Mutz Christopher

HEAD OF RARE DISEASEANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$425K
Net Open-Market Flow
-$425K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Sell(S)4K$74.18$267K94K
Mar 7, 2026Tax withholding(F)3K$74.04$245K98K
Mar 6, 2026Sell(S)2K$74.22$157K101K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001846487-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML